WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

VR System for Cross-modal Rehabilitation of Hemianopia

Not Applicable

Completed

Conditions: Hemianopsia, Homonymous
Hemianopia, Homonymous

Interventions: Device: Cross-model Visual Auditory Rehabilitation

First Posted Date: 2020-01-18

Last Posted Date: 2022-11-30

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 6

Registration Number: NCT04230486

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Liposomal Bupivacaine + Bupivacaine vs. Bupivacaine Alone on Opioid Use After Elective c/Section

Phase 4

Withdrawn

Conditions: Cesarean Section
Postoperative Pain

Interventions: Drug: Liposomal bupivacaine
Drug: Bupivacaine HCl

First Posted Date: 2020-01-18

Last Posted Date: 2024-04-10

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04232306

Locations: 🇺🇸
Atrium Health, Charlotte, North Carolina, United States

A Meditation Intervention on Subconcussive Head Impacts

Not Applicable

Completed

Conditions: Head Injury Trauma

Interventions: Behavioral: Guided Meditation

First Posted Date: 2020-01-13

Last Posted Date: 2023-07-07

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 27

Registration Number: NCT04225663

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Effect of Theta Burst Stimulation on Alcohol Cue Reactivity

Not Applicable

Completed

Conditions: Alcohol Abuse
Alcohol Drinking
Alcohol Use Disorder
Alcohol Dependence
Trauma Injury

Interventions: Device: Real iTBS to the dlPFC
Device: Sham iTBS to the dlPFC

First Posted Date: 2020-01-10

Last Posted Date: 2023-05-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 11

Registration Number: NCT04223154

Locations: 🇺🇸
Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States

CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma

Phase 2

Terminated

Conditions: Relapsed T-Cell Lymphoma
Refractory T-Cell Lymphoma
Non Hodgkin Lymphoma

Interventions: Drug: CPI 613
Drug: Bendamustine

First Posted Date: 2020-01-03

Last Posted Date: 2024-08-21

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 6

Registration Number: NCT04217317

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

TENS and Perioperative Fracture Patients

Active, not recruiting

Conditions: Musculoskeletal Pain

Interventions: Other: Multimodal Pain management including TENS unit
Other: Multimodal Pain management not including TENS unit

First Posted Date: 2019-12-24

Last Posted Date: 2024-12-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 50

Registration Number: NCT04209673

Locations: 🇺🇸
Carolinas Medical Center, Department of Orthopaedic Surgery, Charlotte, North Carolina, United States

Implementation and Effectiveness Trial of HN-STAR

Not Applicable

Recruiting

Conditions: Head and Neck Cancer

Interventions: Other: HN-STAR Intervention

First Posted Date: 2019-12-23

Last Posted Date: 2024-11-07

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 470

Registration Number: NCT04208490

Locations: 🇺🇸
ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States
🇺🇸
John H Stroger Jr Hospital Cook County, Chicago, Illinois, United States
🇺🇸
Kingman Regional Medical Center, Kingman, Arizona, United States

and more 46 locations

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Phase 4

Recruiting

Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)

Interventions: Drug: Topical steroid class I-II
Drug: Doxycyline
Drug: Triamcinolone Acetonide
Drug: Minoxidil

First Posted Date: 2019-12-23

Last Posted Date: 2024-10-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 250

Registration Number: NCT04207931

Locations: 🇺🇸
Wake Forest Baptist Health Department of Dermatology, Winston-Salem, North Carolina, United States

H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil

Not Applicable

Terminated

Conditions: Chronic Pain
Healthy
Opioid Use
Pain, Chronic

Interventions: Device: Real rTMS to the mPFC using H7 Coil
Device: Real rTMS to the dlPFC using H1 Coil

First Posted Date: 2019-12-18

Last Posted Date: 2023-09-15

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 39

Registration Number: NCT04203199

Locations: 🇺🇸
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States

SNIFF Multi-Device Study 2

Phase 2

Suspended

Conditions: Mild Cognitive Impairment
Cognitive Impairment

First Posted Date: 2019-12-16

Last Posted Date: 2024-10-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT04199767

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy